<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>DSpace Collection:</title>
    <link>https://dspace.sduaher.ac.in/jspui/handle/123456789/752</link>
    <description />
    <pubDate>Sun, 08 Feb 2026 22:19:48 GMT</pubDate>
    <dc:date>2026-02-08T22:19:48Z</dc:date>
    <item>
      <title>Dermatology Photo Quiz 1</title>
      <link>https://dspace.sduaher.ac.in/jspui/handle/123456789/9696</link>
      <description>Title: Dermatology Photo Quiz 1
Authors: Rajashekar., T S; Suresh Kumar, K.; Harish Prasanna, R.; Hussain, Kolsawala.; Sumedha, Tirthani.; Hanumanthayya, K
Abstract: Contact dermatitis (CD) is commonly seen in the dermatology OPD cases.&#xD;
10 to 20% of all new cases will be suffering from contact dermatitis. The&#xD;
simple meaning of contact dermatitis is, when a substance come in contact&#xD;
with the skin, the substance may directly damage the skin by its cytotoxic&#xD;
effect, or by stimulating immune competent cells to attack skin and cause&#xD;
damage to the skin. Acids like HCL, HNO3, H2SO4 and alkalis like dish washing&#xD;
soaps, detergents, ammonia, potassium hydroxide, sodium hydroxide and cow&#xD;
urine will damage the skin immediately, and the resultant skin damage is&#xD;
called “Irritant Contact Dermatitis (ICD)”. Some substances of smaller molecular&#xD;
weights (haptens, 500 to 1000 nm) will penetrate the skin, combine with tissue&#xD;
proteins, and then the antigenicity of tissue protein will get altered, the antigen&#xD;
presenting cell will take up this altered molecule, processes it and present it to&#xD;
immune competent cell CD4+T Lymphocyte. Activated CD4+T lymphocyte will&#xD;
proliferate, few become memory cells, and few become sensitized cells. If same&#xD;
hapten come in contact with the body second time, immune competent cells&#xD;
will react aggressively, person will develop inflammation of skin. This reaction&#xD;
is called “Allergic Contact Dermatitis (ACD). Here we are reporting a case of ICD.</description>
      <pubDate>Mon, 01 May 2023 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://dspace.sduaher.ac.in/jspui/handle/123456789/9696</guid>
      <dc:date>2023-05-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>A Comparative Study of Topical Procapil With Platelet-Rich Plasma Therapy Versus Topical Redensyl, Saw Palmetto, and Biotin With Platelet-Rich Plasma Therapy in the Treatment of Androgenetic Alopecia</title>
      <link>https://dspace.sduaher.ac.in/jspui/handle/123456789/9569</link>
      <description>Title: A Comparative Study of Topical Procapil With Platelet-Rich Plasma Therapy Versus Topical Redensyl, Saw Palmetto, and Biotin With Platelet-Rich Plasma Therapy in the Treatment of Androgenetic Alopecia
Authors: Pavithra., T R; Rajashekar, T S; Suresh Kumar, K.; Harish Prasanna, R
Abstract: Background and aim&#xD;
Androgenetic alopecia (AGA) is a well-known hair loss disorder in both men and women affecting&#xD;
approximately 80% and 50% of the population, respectively. Various treatment options for AGA are available&#xD;
with varying efficacy. Combination therapy is a new dictum to combat AGA. Hence, this study aimed to&#xD;
compare the efficacy of commonly used topical therapies such as Procapil with platelet-rich plasma (PRP)&#xD;
and redensyl, saw palmetto (SP), and biotin (RSB) with PRP.&#xD;
Materials and methods&#xD;
This was a randomized controlled trial conducted on 54 male patients with AGA attending the outpatient&#xD;
department in a tertiary care hospital. Participants were randomly assigned into two equal groups (A and B).&#xD;
Group A participants were treated with Procapil with PRP, and group B participants were treated with&#xD;
redensyl, saw palmetto, and biotin with PRP at three weeks intervals for a total period of four sessions.&#xD;
Clinical improvement was assessed by serial hair photography by a third blinded observer and was recorded.&#xD;
Results&#xD;
A total of 54 individuals were included and were distributed into 27 each in group A and group B. AGA&#xD;
grading score was found significant between the groups with P &lt; 0.05.&#xD;
Conclusion&#xD;
PRP with adjuvants redensyl, saw palmetto, and biotin can be a better alternative to the current therapies of&#xD;
PRP.</description>
      <pubDate>Mon, 01 May 2023 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://dspace.sduaher.ac.in/jspui/handle/123456789/9569</guid>
      <dc:date>2023-05-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>A Comparative Study of Intralesional Acyclovir vs Immunotherapy for Treatment of Viral Warts</title>
      <link>https://dspace.sduaher.ac.in/jspui/handle/123456789/9565</link>
      <description>Title: A Comparative Study of Intralesional Acyclovir vs Immunotherapy for Treatment of Viral Warts
Authors: Meghana Reddy., Endela; Rajashekar., T S; Suresh Kumar, K
Abstract: Background: Viral warts are caused by human papillomavirus (HPV), are difficult to treat with conventional&#xD;
modalities, and are cosmetically disfiguring; hence, immunomodulators are being used. The viral origin of&#xD;
warts suggests the antiviral drug acyclovir as a potential therapeutic option. The current study compares the&#xD;
effect of intralesional acyclovir (nucleoside analogue) and intralesional purified protein derivative (PPD)&#xD;
(immunotherapy) in treating various viral warts.&#xD;
Methodology: Prospective observational comparative study was conducted to determine the efficacy of&#xD;
acyclovir, and PPD administered via the intralesional route in patients with viral warts. The study population&#xD;
was categorized into two groups. One group received intralesional acyclovir, and the other received&#xD;
intralesional PPD. Patients were followed-up with for three months. Outcomes considered in our study were&#xD;
recovery (complete, partial, and no recovery) and side effects like pain, burning sensation, and&#xD;
desquamation. Statistical analysis was carried out by coguide software.&#xD;
Results: In our study total of 40 participants, 20 in each group were included. 25 and 15 were of age &lt;30,&#xD;
and ≥ 30, respectively, while 20 were males, and 20 females. Our study reported 60%, and 30% of&#xD;
complete recovery with intralesional acyclovir treatment and intralesional PPD treatment, respectively, in the&#xD;
twelfth week. However, p-value &gt; 0.05 represented no significance between groups. 90% in the acyclovirtreated&#xD;
group presented with pain, and 100% presented with burning sensation, while in the case of PPDtreated&#xD;
group, 60% presented no side effects and the rest 40% showed pain.&#xD;
Conclusions: Intralesional acyclovir is more effective in treating viral warts than PPD. The focus is to be laid&#xD;
on anticipated side effects.</description>
      <pubDate>Mon, 01 May 2023 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://dspace.sduaher.ac.in/jspui/handle/123456789/9565</guid>
      <dc:date>2023-05-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>A Clinicoepidemiological Study of Cutaneous and Systemic Comorbidities of Seborrheic Dermatitis in Adolescent and Adult Females</title>
      <link>https://dspace.sduaher.ac.in/jspui/handle/123456789/9562</link>
      <description>Title: A Clinicoepidemiological Study of Cutaneous and Systemic Comorbidities of Seborrheic Dermatitis in Adolescent and Adult Females
Authors: Rajashekar., T S; Savana, Waikhom.; Suresh Kumar, K.; Meghana Reddy, Endela
Abstract: Background&#xD;
Seborrheic dermatitis is the most common, chronic inflammatory skin condition which is confined to the&#xD;
scalp, nasolabial folds, and regions rich in sebaceous glands for which no definitive cause has been found.&#xD;
Although the disease is more common, the comorbidities associated with it have not been studied in detail.&#xD;
This study aims to assess the prevalence of seborrheic dermatitis and its associated cutaneous and systemic&#xD;
comorbidities in adolescent and adult patients.&#xD;
Methodology&#xD;
This cross-sectional study was performed among 451 adolescent and adult female patients who visited the&#xD;
Department of Dermatology, Venereology, and Leprosy of R. Laxminarayanappa Jalappa Hospital and&#xD;
Research Centre, Kolar. Patients having symptoms such as scaly patches, inflamed skin, and stubborn&#xD;
dandruff were diagnosed with seborrheic dermatitis and included in the study. A detailed history was&#xD;
collected for assessing other cutaneous disorders.&#xD;
Results&#xD;
Out of the 451 female participants, 87% belonged to the age group of 21-30 years, with 60.9% having&#xD;
cutaneous and 28.3% having systemic comorbidities. Acne (13.3%) and diabetes mellitus (13.1%) were the&#xD;
most common cutaneous and systemic associated comorbidities, respectively.&#xD;
Conclusions&#xD;
Comorbidities of seborrheic dermatitis were more commonly seen in adult female patients, Some of the&#xD;
common cutaneous comorbidities were acne, alopecia areata, and folliculitis. Systemic comorbidities&#xD;
included diabetes, obesity, and hypertension. However, all of these comorbidities were not statistically&#xD;
significant.</description>
      <pubDate>Thu, 01 Jun 2023 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://dspace.sduaher.ac.in/jspui/handle/123456789/9562</guid>
      <dc:date>2023-06-01T00:00:00Z</dc:date>
    </item>
  </channel>
</rss>

